Skip to main content

Advertisement

Log in

Primary pituitary lymphoma: an update of the literature

  • Topic Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Primary intracranial lymphomas (Weller et al. in Neuro Oncol 14(12):1481–1484, 2012) are an emerging disease and an isolated localization in the pituitary gland i.e. primary pituitary lymphoma (PPL) represents a rare condition. We present an update of the most recent evidence for PPL through a systematic review of the literature. A systematic literature review was conducted using PubMed database up to October 2015. The population was defined as immunocompetent patients with a pathologically confirmed diagnosis of PPL. Patients’ characteristics, clinical presentation, radiological features, pathology reports, adjuvant treatment and follow-up data were analyzed. We reported one case of PPL and included our data in this analysis. A total of 33 cases of PPL were identified, including ours. A slight not significant female prevalence was evident, with a mean age of 59 years at diagnosis. Visual troubles and headaches were the most common presenting symptoms. About 80 % of patients presented a cranial nerve (CN) deficit. The most frequently involved were the II and III CN. Anterior hypopituitarism was present in 70 % of cases and a diabetes insipidus in 36 % of cases. PPL was rarely limited to the sella and most often extended to the suprasellar and parasellar space. 70 % of cases underwent resection, 21 % a biopsy. A B-cell lymphoma was isolated in 82 % of cases, a T-cell lymphoma in 15 % and a NK/T cell lymphoma in one case. Overall mean survival rate was 14.4 months (95 % confidence interval 9.0–19.8 months) and there was no difference in terms of survival rates when patients were stratified according to the treatment they received. PPL is an emerging clinical entity. Literature data are too scarce to allow the definition of specific protocols of treatment and the management is based on the guidelines present for PCNSL. The role of surgery aiming at a complete resection of PPL should be reevaluated in wider studies including only this category of patients, to establish the real role of each therapeutic strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Clayton RN (1999) Sporadic pituitary tumours: from epidemiology to use of databases. Bailliere’s Best Pract Res Clin Endocrinol Metab 13(3):451–460

  2. Famini P, Maya MM, Melmed S (2011) Pituitary magnetic resonance imaging for sellar and parasellar masses: 10-year experience in 2598 patients. J Clin Endocrinol Metab 96(6):1633–1641

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Weller M, Martus P, Roth P, Thiel E, Korfel A, German PSG (2012) Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro Oncol 14(12):1481–1484

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fine HA, Mayer RJ (1993) Primary central nervous system lymphoma. Ann Intern Med 119(11):1093–1104

    Article  CAS  PubMed  Google Scholar 

  5. Snider WD, Simpson DM, Aronyk KE, Nielsen SL (1983) Primary lymphoma of the nervous system associated with acquired immune-deficiency syndrome. N Engl J Med 308(1):45

    CAS  PubMed  Google Scholar 

  6. Samaratunga H, Perry-Keene D, Apel RL (1997) Primary lymphoma of pituitary gland: a neoplasm of acquired malt? Endocr Pathol 8(4):335–341

    Article  PubMed  Google Scholar 

  7. Shaw JA, Strachan FM, Sawers HA, Bevan JS (1997) Non-Hodgkin lymphoma with panhypopituitarism, hyperprolactinaemia and sixth nerve palsy. J R Soc Med 90(5):274–275

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Kuhn D, Buchfelder M, Brabletz T, Paulus W (1999) Intrasellar malignant lymphoma developing within pituitary adenoma. Acta Neuropathol (Berl) 97(3):311–316

    Article  CAS  Google Scholar 

  9. Au WY, Kwong YL, Shek TW, Leung G, Ooi C (2000) Diffuse large-cell B-cell lymphoma in a pituitary adenoma: an unusual cause of pituitary apoplexy. Am J Hematol 63(4):231–232

    Article  CAS  PubMed  Google Scholar 

  10. Mathiasen RA, Jarrahy R, Cha ST, Kovacs K, Herman VS, Ginsberg E et al (2000) Pituitary lymphoma: a case report and literature review. Pituitary 2(4):283–287

    Article  CAS  PubMed  Google Scholar 

  11. Giustina A, Gola M, Doga M, Rosei EA (2001) Clinical review 136: primary lymphoma of the pituitary: an emerging clinical entity. J Clin Endocrinol Metab 86(10):4567–4575

    Article  CAS  PubMed  Google Scholar 

  12. Landman RE, Wardlaw SL, McConnell RJ, Khandji AG, Bruce JN, Freda PU (2001) Pituitary lymphoma presenting as fever of unknown origin. J Clin Endocrinol Metab 86(4):1470–1476

    CAS  PubMed  Google Scholar 

  13. Kaufmann TJ, Lopes MB, Laws ER Jr, Lipper MH (2002) Primary sellar lymphoma: radiologic and pathologic findings in two patients. Am J Neuroradiol 23(3):364–367

    PubMed  Google Scholar 

  14. Katz BJ, Jones RE, Digre KB, Warner JE, Moore KR (2003) Panhypopituitarism as an initial manifestation of primary central nervous system non-Hodgkin’s lymphoma. Endocr Pract 9(4):296–300

    Article  PubMed  Google Scholar 

  15. Lee JH, Lee HK, Choi CT, Huh J (2002) Mucosa-associated lymphoid tissue lymphoma of the pituitary gland: MR imaging features. Am J Neuroradiol 23(5):838–840

    PubMed  Google Scholar 

  16. Huang YY, Lin SF, Dunn P, Wai YY, Hsueh C, Tsai JS (2005) Primary pituitary lymphoma presenting as hypophysitis. Endocr J 52(5):543–549

    Article  PubMed  Google Scholar 

  17. Liu JK, Sayama C, Chin SS, Couldwell WT (2007) Extranodal NK/T-cell lymphoma presenting as a pituitary mass. Case report and review of the literature. J Neurosurg 107(3):660–665

    Article  PubMed  Google Scholar 

  18. Rudnik A, Larysz D, Blamek S, Larysz P, Bierzynska-Macyszyn G, Wlaszczuk P et al (2007) Primary pituitary lymphoma. Folia Neuropathologica/Association of Polish Neuropathologists and Medical Research Centre. Pol Acad Sci 45(3):144–148

    Google Scholar 

  19. Chen SM, Chang CN, Wei KC, Jung SM, Chuang CC (2008) Sellar lymphoma mimicking sphenoid infection presenting with cavernous sinus syndrome. J Clin Neurosci 15(10):1148–1151

    Article  PubMed  Google Scholar 

  20. Kozakova D, Machalekova K, Brtko P, Szepe P, Vanuga P, Pura M (2008) Primary B-cell pituitary lymphoma of the Burkitt type: case report of the rare clinic entity with typical clinical presentation. Cas Lek Cesk 147(11):569–573

    CAS  PubMed  Google Scholar 

  21. Romeike BF, Joellenbeck B, Stein H, Loddenkemper C, Hummel M, Firsching R et al (2008) Precursor T-lymphoblastic lymphoma within a recurrent pituitary adenoma. Acta Neurochir (Wien) 150(8):833–836

    Article  CAS  Google Scholar 

  22. Moshkin O, Muller P, Scheithauer BW, Juco J, Horvath E, Patterson BJ et al (2009) Primary pituitary lymphoma: a histological, immunohistochemical, and ultrastructural study with literature review. Endocr Pathol 20(1):46–49

    Article  PubMed  Google Scholar 

  23. Quintero Wolfe S, Hood B, Barker J, Benveniste RJ (2009) Primary central nervous system lymphoma mimicking pituitary apoplexy: case report. Pituitary 12(1):76–79

    Article  PubMed  Google Scholar 

  24. Tamer G, Kartal I, Aral F (2009) Pituitary infiltration by non-Hodgkin’s lymphoma: a case report. J Med Case Rep 3:9293

    Article  PubMed  PubMed Central  Google Scholar 

  25. Bayraktar S, Bassini W, Goodman M (2010) Primary pituitary lymphoma: idiopathic anasarca with relapse in bone marrow only. Acta Haematol 123(2):121–125

    Article  PubMed  Google Scholar 

  26. Hayasaka K, Koyama M, Yamashita T (2010) Primary pituitary lymphoma diagnosis by FDG-PET/CT. Clin Nucl Med 35(3):205

    Article  PubMed  Google Scholar 

  27. Martinez JH, Davila Martinez M, Mercado de Gorgola M, Montalvo LF, Tome JE (2011) The coexistence of an intrasellar adenoma, lymphocytic hypophysitis, and primary pituitary lymphoma in a patient with acromegaly. Case Rep Endocrinol 2011:941738

    PubMed  PubMed Central  Google Scholar 

  28. Anila KR, Nair RA, Koshy SM, Jacob PM (2012) Primary intravascular large B-cell lymphoma of pituitary. Indian J Pathol Microbiol 55(4):549–551

    Article  CAS  PubMed  Google Scholar 

  29. Carrasco CA, Rojas ZD, Chiorino R, Gonzalez G (2012) Primary pituitary lymphoma in immunocompetent patient: diagnostic problems and prolonged follow-up. Pituitary 15(1):93–96

    Article  PubMed  Google Scholar 

  30. Li Y, Zhang Y, Xu J, Chen N (2012) Primary pituitary lymphoma in an immunocompetent patient: a rare clinical entity. J Neurol 259(2):297–305

    Article  PubMed  Google Scholar 

  31. Papanastasiou L, Pappa T, Dasou A, Kyrodimou E, Kontogeorgos G, Samara C et al (2012) Case report: primary pituitary non-Hodgkin’s lymphoma developed following surgery and radiation of a pituitary macroadenoma. Hormones 11(4):488–494

    Article  PubMed  Google Scholar 

  32. Rainsbury P, Mitchell-Innes A, Clifton N, Khalil H (2012) Primary lymphoma of the pituitary gland: an unusual cause of hemianopia in an immunocompetent patient. JRSM Short Rep 3(8):55

    Article  PubMed  PubMed Central  Google Scholar 

  33. Wiens AL, Hagen MC, Bonnin JM, Rizzo KA (2012) T-cell lymphoblastic lymphoma/leukemia presenting as a pituitary mass lesion: a case report and review of the literature. Neuropathology 32(6):668–674

    Article  PubMed  Google Scholar 

  34. Wilkie MD, Al-Mahfoudh R, Javadpour M (2012) A rare case of primary sellar lymphoma presenting a diagnostic challenge. Br J Neurosurg 26(5):782–783

    Article  PubMed  Google Scholar 

  35. Singh VP, Mahapatra AK, Dinde AK (1993) Sellar-suprasellar primary malignant lymphoma: case report. Indian J Cancer 30(2):88–91

    CAS  PubMed  Google Scholar 

  36. Freda PU, Post KD (1999) Differential diagnosis of sellar masses. Endocrinol Metab Clin N Am 28(1):81–117

    Article  CAS  Google Scholar 

  37. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62(11):2461–2465

    Article  CAS  PubMed  Google Scholar 

  38. Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M et al (1998) Increased incidence of neoplasia in patients with pituitary adenomas. The pituitary study group. Clin Endocrinol (Oxf) 49(4):441–445

    Article  CAS  Google Scholar 

  39. O’Neal KD, Schwarz LA, Yu-Lee LY (1991) Prolactin receptor gene expression in lymphoid cells. Mol Cell Endocrinol 82(2–3):127–135

    Article  PubMed  Google Scholar 

  40. Messerer M, De Battista JC, Raverot G, Kassis S, Dubourg J, Lapras V et al (2011) Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg Focus 30(4):E11

    Article  PubMed  Google Scholar 

  41. Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M et al (2000) Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92(2):261–266

    Article  CAS  PubMed  Google Scholar 

  42. Bellinzona M, Roser F, Ostertag H, Gaab RM, Saini M (2005) Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases. Eur J Surg Oncol 31(1):100–105

    Article  CAS  PubMed  Google Scholar 

  43. Lai R, Rosenblum MK, DeAngelis LM (2002) Primary CNS lymphoma: a whole-brain disease? Neurology 59(10):1557–1562

    Article  PubMed  Google Scholar 

  44. Korfel A, Thiel E, Martus P, Mohle R, Griesinger F, Rauch M et al (2015) Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology 84(12):1242–1248

    Article  CAS  PubMed  Google Scholar 

  45. Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M et al (2010) High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 11(11):1036–1047

    Article  CAS  PubMed  Google Scholar 

  46. Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B et al (2013) Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol 31(31):3971–3979

    Article  CAS  PubMed  Google Scholar 

  47. Kumar R, Laack N, Pollock BE, Link M, O’Neill BP, Parney IF (2015) Stereotactic radiosurgery in the treatment of recurrent CNS lymphoma. World Neurosurg 84(2):390–397

    Article  PubMed  Google Scholar 

  48. Kenai H, Yamashita M, Nakamura T, Asano T, Momii Y, Nagatomi H (2006) Gamma Knife surgery for primary central nervous system lymphoma: usefulness as palliative local tumor control. J Neurosurg 105(Suppl):133–138

    PubMed  Google Scholar 

  49. Hirono S, Iwadate Y, Higuchi Y, Serizawa T, Nagano O, Matsutani T et al (2015) Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma. J Neuro Oncol 123(2):237–244

    Article  CAS  Google Scholar 

  50. Kasenda B, Ferreri AJ, Marturano E, Forst D, Bromberg J, Ghesquieres H et al (2015) First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis. Ann Oncol 26(7):1305–1313

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Gerstner ER, Carson KA, Grossman SA, Batchelor TT (2008) Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation. Neurology 70(5):401–402

    Article  PubMed  PubMed Central  Google Scholar 

  52. Yang SH, Lee KS, Kim IS, Hong JT, Sung JH, Son BC et al (2009) Long-term survival in primary CNS lymphoma treated by high-dose methotrexate monochemotherapy: role of STAT6 activation as prognostic determinant. J Neuro Oncol 92(1):65–71

    Article  CAS  Google Scholar 

  53. Jahnke K, Thiel E, Martus P, Herrlinger U, Weller M, Fischer L et al (2006) Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neuro Oncol 80(2):159–165

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Messerer.

Ethics declarations

Conflict of interest

None.

Additional information

A. Tarabay and G. Cossu have contributed equally to the conception of the work and analysis of data, drafting and revision and final approval of the version to be published.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tarabay, A., Cossu, G., Berhouma, M. et al. Primary pituitary lymphoma: an update of the literature. J Neurooncol 130, 383–395 (2016). https://doi.org/10.1007/s11060-016-2249-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2249-z

Keywords

Navigation